Skip to search formSkip to main contentSkip to account menu

Evaluable Disease

Known as: Evaluable 
Disease that cannot be measured directly by the size of the tumor but can be evaluated by other methods specific to a particular clinical trial.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Predicting responses to immunotherapy Colon cancers with loss-of-function mutations in the mismatch repair (MMR) pathway have… 
Review
2008
Review
2008
Treating Tobacco Use and Dependence: 2008 Update
s obtained Abstracts reviewed for inclusion/exclusion criteria by literature reviewerss reviewed for inclusion/exclusion criteria… 
Highly Cited
2006
Highly Cited
2006
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
Highly Cited
2003
Highly Cited
2003
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].
PURPOSE To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839]; AstraZeneca, Wilmington, DE), a… 
Highly Cited
2002
Highly Cited
2002
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
Highly Cited
2001
Highly Cited
2001
Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU).
CONTEXT Delirium is a common problem in the intensive care unit (ICU). Accurate diagnosis is limited by the difficulty of… 
Highly Cited
2000
Highly Cited
2000
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
Highly Cited
2000
Highly Cited
2000
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
PURPOSE To evaluate whether treatment with single-agent docetaxel would result in longer survival than would best supportive care… 
Highly Cited
1999
Highly Cited
1999
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation…
CONTEXT Raloxifene hydrochloride, a selective estrogen receptor modulator, prevents bone loss in postmenopausal women, but… 
Highly Cited
1987
Highly Cited
1987
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.
We studied the effects of adoptive immunotherapy with lymphokine-activated killer (LAK) cells plus interleukin-2 or therapy with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)